Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora |
| |
Authors: | Finegold S M Molitoris D Väisänen M-L |
| |
Institution: | S. M. Finegold, D. Molitoris, and M.-L. Väisänen |
| |
Abstract: | Rifaximin, ampicillin-sulbactam, neomycin, nitazoxanide, teicoplanin, and vancomycin were tested against 536 strains of anaerobic bacteria. The overall MIC of rifaximin at which 50% of strains were inhibited was 0.25 μg/ml. Ninety percent of the strains tested were inhibited by 256 μg/ml of rifaximin or less, an activity equivalent to those of teicoplanin and vancomycin but less than those of nitazoxanide and ampicillin-sulbactam. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|